{"id":184798,"name":"HEARST CORPORATION","slug":"hearst-corporation","state":null,"country":"* Undetermined","description":"","totalSpending":2720000,"filings":32,"yearlySpending":[{"year":2018,"income":280000},{"year":2019,"income":280000},{"year":2020,"income":360000},{"year":2021,"income":360000},{"year":2022,"income":360000},{"year":2023,"income":360000},{"year":2024,"income":360000},{"year":2025,"income":360000}],"issues":["CSP","PHA","HCR","MIA","COM","LAW","VET","CPI"],"firms":["INVARIANT LLC"],"lobbyists":["HEATHER PODESTA","BENJAMIN KLEIN","LARISSA MARTINEZ","ANNE PALISI","JONATHAN BECKER","ERIC ROSEN","KATHRYN WISE","CHRISTOPHER GILLOTT","ANNABELL STOKES","JOEL RICHARD","STEPHEN WEYLER","JESSICA HATCHER","KAETLYN FANNING","DREW GRIFFIN"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Food & Drug Administration (FDA)","HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)","Natl Economic Council (NEC)","Executive Office of the President (EOP)","Office of Management & Budget (OMB)","Substance Abuse & Mental Health Services Administration (SAMHSA)","Labor, Dept of (DOL)","Treasury, Dept of"],"sampleDescriptions":["Monitor issues related to data privacy and data security.","Monitor efforts to streamline patient medication information and FDA guidance related to biosimilar naming conventions.","Monitor health policy issues, including implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidenced-based care guidelines; discuss e","Monitor efforts to strengthen journalist protections.","Monitor issues related to data privacy and data security."],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}